The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

At confirmation hearing, Heidi Overton sidesteps questions about FDA regulation of fruit-flavored vapes

Trump administration pulls 750,000 people from ACA coverage, claiming fraud

HHS issues direct final rule to reduce reliance on animal testing

NCI launches AI tool to help match patients to clinical trials

EPA stops publishing air pollution cancer risk data

Kennedy overhauls “too woke” USPSTF with the appointment of eight members

Clinical Roundup

Tagrisso increased OS in early-stage EGFR-mutated lung cancer at eight year follow-up, ADAURA phase III trial finds

PDS0101 + pembrolizumab in HPV16+ R/M head and neck cancer show anti-tumor activity, VERSATILE-002 phase II study finds

Blood test could guide future treatment in Ewing sarcoma, Dana-Farber study finds

COA survey finds high bispecific therapy adoption among community oncology practices

ASCO expresses support for functional precision medicine, rescinding past objections

EGFR mutation linked to dramatically increased lung cancer risk

In The Clinic

mRNA vaccine for melanoma is hailed as a turning point in medicine
The data from Moderna and Merck’s trial have yet to be presented

FreeGuest Editorial
Guest Editorial
Trials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account